RegMol · The most advanced HELM implementation to support every therapeutic modality including ADCs, peptides, oligonucleotides and small molecules. · See how it works ↗

Scilligence ELN Selected by WuXi AppTec for Knowledge Management and Collaboration

  • Boston, June 4, 2014

https://scilligence.com/wp-content/uploads/2018/12/Spring_rd_informatics_workshop_west-3-2-1.jpg Corporation announces today that WuXi AppTec, a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company, has licensed https://scilligence.com/wp-content/uploads/2018/12/Spring_rd_informatics_workshop_west-3-2-1.jpg ELN for knowledge management and collaboration. https://scilligence.com/wp-content/uploads/2018/12/Spring_rd_informatics_workshop_west-3-2-1.jpg ELN, a cross-platform web-based ELN system, will enable WuXi AppTec to better serve the needs of customers globally. Customers can have real-time access to experimental data and provide instant feedback to Wuxi’s scientists in a secure and productive manner.

About WuXi AppTec
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company with global operations. WuXi AppTec provides a broad and integrated portfolio of services to help worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through an array of cost-effective and efficient solutions.
http://www.wuxiapptec.com

About https://scilligence.com/wp-content/uploads/2018/12/Spring_rd_informatics_workshop_west-3-2-1.jpg
https://scilligence.com/wp-content/uploads/2018/12/Spring_rd_informatics_workshop_west-3-2-1.jpg is a leading innovator of web-based cheminformatics and bioinformatics solutions designed for any device, browser, and platform. https://scilligence.com/wp-content/uploads/2018/12/Spring_rd_informatics_workshop_west-3-2-1.jpg’s tools enhance the knowledge sharing and productivity of researchers in discovery and development of small molecule and biologic therapeutics.

Scroll to Top